Form 8-K
Material Company Update
2026-04-24
SANA filed 8-K — material company event
Sana Biotechnology, Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Latest SEC filings for Sana Biotechnology, Inc. (SANA) explained in plain English: insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). Sourced directly from SEC EDGAR.
Sana Biotechnology, Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Sana Biotechnology, Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Bishop Hans Edgar (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Harr Steve (Director, President & CEO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Wyrick Susan D. (See Remarks) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Wyrick Susan D. (See Remarks) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Harr Steve (Director, President & CEO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Wyrick Susan D. (See Remarks) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Sana Biotechnology, Inc. filed its annual report with the SEC. This report includes audited financial statements, business overview, risk factors, and management discussion.
Sana Biotechnology, Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Piper Brian (EVP, Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Sana Biotechnology, Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Sana Biotechnology, Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer
Bishop Hans Edgar (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Wyrick Susan D. (See Remarks) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.